Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | RXRB | P28702 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9342895 | 1.00 | IDO1 (0.64) | IDO1TSHRAPPMAOBCYP2A6 | |
| SCHEMBL134086 | 0.92 | IDO1 (0.61) | IDO1TSHRAPPMAOBCYP2A6 | |
| SCHEMBL2657770 | 0.90 | TSHR (0.71) | IDO1TSHRAPPMAOBRXRA | |
| SCHEMBL9342899 | 0.89 | IDO1 (0.58) | IDO1TSHRAPPMAOBCYP2A6 | |
| SCHEMBL21578433 | 0.89 | IDO1 (0.58) | IDO1TSHRAPPMAOBCYP2A6 | |
| SCHEMBL9342149 | 0.89 | IDO1 (0.58) | IDO1TSHRAPPMAOBCYP2A6 | |
| SCHEMBL668783 | 0.88 | APP (0.68) | IDO1TSHRAPPMAOB | |
| SCHEMBL8681291 | 0.88 | IDO1 (0.52) | IDO1TSHRAPPMAOBNPC1 | |
| SCHEMBL10857758 | 0.87 | IDO1 (0.56) | IDO1TSHRAPPMAOBCYP2A6 | |
| SCHEMBL10997023 | 0.87 | IDO1 (0.56) | IDO1TSHRAPPMAOBCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117976970-A | Electrolyte, battery monomer, preparation method of battery monomer, battery and power utilization device | 宁德时代新能源科技股份有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-116421892-B | Full-cladding atomizing cover for plasma beauty instrument | 深圳虹望奈喜美电器有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116421892-A | Full-cladding atomizing cover for plasma beauty instrument | 深圳虹望奈喜美电器有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-114853795-A | Arylboron compound of conjugated olefin and preparation method and application thereof | 南京工业大学 | 2022-08-05 | — | — | CN | claimed |
| WO-2021216722-A1 | STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES | Atea Pharmaceuticals, Inc. (US) | 2021-10-28 | — | — | WO | claimed |
| US-8580992-B1 | Compounds and methods of arylmethylation (benzylation) as protection for alcohol groups during chemical synthesis | The Florida State University Research Foundation, Inc. (US) | 2013-11-12 | — | — | US | claimed |
| US-20100256383-A1 | Compounds and Methods of Arylmethylation (Benzylation) As Protection For Alcohol Groups During Chemical Synthesis | DUDLEY GREGORY | 2010-10-07 | — | — | US | claimed |
| US-7166723-B2 | Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline | WYETH (US) | 2007-01-23 | — | — | US | claimed |
| US-20060074240-A1 | Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline | WYETH (US) | 2006-04-06 | — | — | US | claimed |
| CN-1247590-C | Process for synthesis of derivatives of 2,30dihydro-1,4-dioxino-[2,3-f]quinoline | WYETH CORP (US) | 2006-03-29 | — | — | CN | claimed |
| US-20040186123-A1 | Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline | WYETH | 2004-09-23 | — | — | US | claimed |
| CN-1509290-A | Process for synthesis of derivatives of 2,30dihydro-1,4-dioxino-[2,3-f]quinoline | — | 2004-06-30 | — | — | CN | claimed |
| EP-1387845-A2 | PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE | Wyeth (US) | 2004-02-11 | — | — | EP | claimed |
| EP-0627433-B1 | PROCESS FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE AND INTERMEDIATE | EISAI CO LTD (JP) | 2003-03-05 | — | — | EP | claimed |
| US-20020187983-A1 | Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline | WYETH | 2002-12-12 | — | — | US | claimed |
| WO-2002092602-A2 | PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE | WYETH (US) | 2002-11-21 | — | — | WO | claimed |
| US-5557002-A | Process for the preparation of biphenyl containing intermediates useful in making angiotensin II receptor antagonists | EISAI CO., LTD. (JP) | 1996-09-17 | — | — | US | claimed |
| US-5554757-A | Process for the preparation of imidazopyridine derivatives, and intermediates therefore | EISAI CO., LTD. (JP) | 1996-09-10 | — | — | US | claimed |
| EP-0627433-A1 | PROCESS FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE AND INTERMEDIATE | Eisai Co., Ltd. (JP) | 1994-12-07 | — | — | EP | claimed |
| JP-7061977-A | — | — | None | — | — | JP | disclosed |
| JP-7061952-A | — | — | None | — | — | JP | disclosed |
| EP-4604951-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | AMIRA THERAPEUTICS, S.L. (ES) | 2025-08-27 | — | — | EP | disclosed |
| US-20240383893-A1 | Hydroxamic Acid Compound Having ENPP1 Inhibitory Activity and Use Thereof | HAIHE BIOPHARMA CO., LTD. (CN) | 2024-11-21 | — | — | US | disclosed |
| CN-118496071-A | Method for preparing C1 deuterated aldehyde by ether oxidative cleavage | 华东理工大学 | 2024-08-16 | — | — | CN | disclosed |
| EP-4400493-A1 | HYDROXAMIC ACID COMPOUND HAVING ENPP1 INHIBITORY ACTIVITY AND USE THEREOF | Haihe Biopharma Co., Ltd. (CN) | 2024-07-17 | — | — | EP | disclosed |
| US-12006311-B2 | Compounds for use in preventing or treating cancer | FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRONINSTITUT DE RECERCA (ES) | 2024-06-11 | — | — | US | disclosed |
| WO-2024083861-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | SELABTEC SCIENCES, SLU (ES) | 2024-04-25 | — | — | WO | disclosed |
| EP-4356909-A1 | 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES DERIVATIVES AND USE THEREOF | Selabtec Sciences, SLU (ES) | 2024-04-24 | — | — | EP | disclosed |
| CN-116421892-B | Full-cladding atomizing cover for plasma beauty instrument | 深圳虹望奈喜美电器有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-116421892-A | Full-cladding atomizing cover for plasma beauty instrument | 深圳虹望奈喜美电器有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116239544-A | Preparation method of bisresorcinol-based triazine and triazine ultraviolet absorbent | 黄冈美丰化工科技有限公司 | 2023-06-09 | — | — | CN | disclosed |
| EP-3271468-B1 | DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES | LABORATORIO TECNICO DE SEGURIDAD Y ESTANDARIZACION SL (ES) | 2022-12-14 | — | — | EP | disclosed |
| EP-3813832-B1 | COMPOUNDS FOR USE IN PREVENTING OR TREATING CANCER | FUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA (ES) | 2022-11-09 | — | — | EP | disclosed |
| CN-114853795-A | Arylboron compound of conjugated olefin and preparation method and application thereof | 南京工业大学 | 2022-08-05 | — | — | CN | disclosed |
| CN-110201721-B | Complex compounds | 庄信万丰股份有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114716453-A | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | 卫材R&D管理有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-109942560-B | Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B | 卫材R&D管理有限公司 | 2022-06-17 | — | — | CN | disclosed |
| US-11332477-B2 | Nitrogen containing heterocycle substituted benzoxazine oxazolidinone compound and preparation method and use thereof | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2022-05-17 | — | — | US | disclosed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | disclosed |
| CN-114292248-A | Method for synthesizing Latemozu intermediate | 广东莱佛士制药技术有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-107849594-B | Deamination of organophosphorus nucleosides | 科技学专业学院有限公司 | 2022-01-18 | — | — | CN | disclosed |
| CN-108727406-B | Nitrogen heterocyclic ring substituted benzoxazine oxazolidinone compound and preparation method and application thereof | 北京协和制药二厂 | 2021-12-07 | — | — | CN | disclosed |
| CN-113454054-A | A series of compounds for treating skin diseases and other conditions | 尤尼根公司 | 2021-09-28 | — | — | CN | disclosed |
| US-20210230150-A1 | COMPOUNDS FOR USE IN PREVENTING OR TREATING CANCER | AMIRA THERAPEUTICS, S.L. (ES) | 2021-07-29 | — | — | US | disclosed |
| CN-108586500-B | Zinc coordination complex and method for preparing organic zinc reagent | 慕尼黑路德维希马克西米利安斯大学 | 2021-06-25 | — | — | CN | disclosed |
| US-20210188871-A1 | NITROGEN CONTAINING HETEROCYCLE SUBSTITUTED BENZOXAZINE OXAZOLIDINONE COMPOUND AND PREPARATION METHOD AND USE THEREOF | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2021-06-24 | — | — | US | disclosed |
| CN-106362797-B | Oxalic acid amide ligand and application thereof in copper-catalyzed aryl halide coupling reaction | 浙江中科创越药业有限公司 | 2021-05-28 | — | — | CN | disclosed |
| EP-3813832-A1 | COMPOUNDS FOR USE IN PREVENTING OR TREATING CANCER | Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (ES) | 2021-05-05 | — | — | EP | disclosed |
| CN-112047816-A | Method for synthesizing ether by catalyzing alcohol with trimethylhalosilane | 扬州大学 | 2020-12-08 | — | — | CN | disclosed |
| CN-106661071-B | Complex compounds | 庄信万丰股份有限公司 | 2020-06-09 | — | — | CN | disclosed |
| US-20180066295-A1 | DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES | LABORATORIO TECNICO DE SEGURIDAD Y ESTANDARIZACION, S.L.U. (ES) | 2018-03-08 | — | — | US | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| EP-1961756-B1 | NOVEL BISBORON COMPOUND | JAPAN SCIENCE & TECH AGENCY (JP) | 2016-04-27 | — | — | EP | disclosed |
| US-9065062-B2 | Cross-linkable iridium complexes and organic light-emitting devices using the same | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-23 | — | — | US | disclosed |
| US-8853424-B2 | Protein cross-linking inhibitor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-10-07 | — | — | US | disclosed |
| JP-5296109-B2 | — | — | 2013-09-25 | — | — | JP | disclosed |
| US-20120107989-A1 | CROSS-LINKABLE IRIDIUM COMPLEXES AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME | UNIVERSAL DISPLAY CORPORATION | 2012-05-03 | — | — | US | disclosed |
| US-8119255-B2 | First and second electrode; a first organic layer between the electrodes; the first organic layer is a non-electroluminescent, cross-linked metal complex; and a second organic layer is an emissive electroluminescent organic material | UNIVERSAL DISPLAY CORPORATION (US) | 2012-02-21 | — | — | US | disclosed |
| US-8017809-B2 | Bisboron compound | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20110212919-A1 | PROTEIN CROSS-LINKING INHIBITOR | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2011-09-01 | — | — | US | disclosed |
| US-20100087645-A1 | NOVEL BISBORON COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-08 | — | — | US | disclosed |
| US-7439364-B2 | Process for the synthesis of derivatives of halo-[2,3-F] quinoline | WYETH (US) | 2008-10-21 | — | — | US | disclosed |
| US-20080220265-A1 | Cross-linkable Iridium Complexes and Organic Light-Emitting Devices Using the Same | UNIVERSAL DISPLAY CORPORATION (US) | 2008-09-11 | — | — | US | disclosed |
| EP-1961756-A1 | NOVEL BISBORON COMPOUND | Japan Science and Technology Agency (JP) | 2008-08-27 | — | — | EP | disclosed |
| WO-2008073440-A2 | CROSS-LINKABLE IRIDIUM COMPLEXES AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME | UNIVERSAL DISPLAY CORPORATION (US) | 2008-06-19 | — | — | WO | disclosed |
| US-20070231467-A1 | METHOD FOR MANUFACTURING LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2007-10-04 | — | — | US | disclosed |
| US-20070218190-A1 | METHOD FOR MANUFACTURING LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070123705-A1 | Process for the Synthesis of Derivatives of 2,3-Dihydro-1,4-Dioxino-[2,3-f] Quinolines | WYETH (US) | 2007-05-31 | — | — | US | disclosed |
| US-7166723-B2 | Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline | WYETH (US) | 2007-01-23 | — | — | US | disclosed |
| CN-1854128-A | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-11-01 | — | — | CN | disclosed |
| US-7102023-B2 | Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-09-05 | — | — | US | disclosed |
| CN-1266112-C | Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation | MASSACHUSETTS INST TECHNOLOGY (US) | 2006-07-26 | — | — | CN | disclosed |
| US-7038052-B2 | Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline | WYETH (US) | 2006-05-02 | — | — | US | disclosed |
| US-20060074240-A1 | Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline | WYETH (US) | 2006-04-06 | — | — | US | disclosed |
| CN-1247590-C | Process for synthesis of derivatives of 2,30dihydro-1,4-dioxino-[2,3-f]quinoline | WYETH CORP (US) | 2006-03-29 | — | — | CN | disclosed |
| US-20040220389-A1 | Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-11-04 | — | — | US | disclosed |
| US-20040186123-A1 | Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline | WYETH | 2004-09-23 | — | — | US | disclosed |
| EP-1004621-B1 | GAMMA-RAY STABILIZER AND THERMOPLASTIC POLYMER COMPOSITION CONTAINING THE SAME | TEIJIN CHEMICALS LTD (JP) | 2004-09-15 | — | — | EP | disclosed |
| CN-1509290-A | Process for synthesis of derivatives of 2,30dihydro-1,4-dioxino-[2,3-f]quinoline | — | 2004-06-30 | — | — | CN | disclosed |
| US-6693178-B2 | HALOGENATED BENZYL ETHER GALACTOPYRANOSIDE, GLUCOPYRANOSIDE, RIBOFURANOSIDE OR XYLOFURANOSIDE DERIVATIVES; STABLE, EASILY REMOVED | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2004-02-17 | — | — | US | disclosed |
| US-6693197-B2 | Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino- [2,3-f] quinoline | WYETH | 2004-02-17 | — | — | US | disclosed |
| EP-1387845-A2 | PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-(2,3-f) QUINOLINE | Wyeth (US) | 2004-02-11 | — | — | EP | disclosed |
| US-20030181690-A1 | Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-09-25 | — | — | US | disclosed |
| EP-0627433-B1 | PROCESS FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE AND INTERMEDIATE | EISAI CO LTD (JP) | 2003-03-05 | — | — | EP | disclosed |
| US-20020187983-A1 | Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline | WYETH | 2002-12-12 | — | — | US | disclosed |
| US-6485657-B1 | Gamma-ray stabilizer and thermoplastic polymer compound including the said stabilizer | TEIJIN, LIMITED (JP) | 2002-11-26 | — | — | US | disclosed |
| WO-2002092602-A2 | PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE | WYETH (US) | 2002-11-21 | — | — | WO | disclosed |
| CN-1368884-A | Method for modulating FXR receptor activity | ALLERGAN SALES INC (US) | 2002-09-11 | — | — | CN | disclosed |
| CN-1368975-A | Organosilyl compounds having nuclear hormone receptor modulating activity | ALLERGAN SALES INC (US) | 2002-09-11 | — | — | CN | disclosed |
| EP-1233970-A2 | PROTECTING GROUPS USEFUL IN THE SYNTHESIS OF POLYSACCHARIDES, NATURAL PRODUCTS, AND COMBINATORIAL LIBRARIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-08-28 | — | — | EP | disclosed |
| US-6426421-B1 | HALOGENATED BENZYL ETHER-BASED PROTECTING GROUPS FOR FUNCTIONAL GROUPS, OF ALCOHOLS, THIOLS, AMINES, CARBOXYLIC ACIDS, AND PHOSPHORIC ACIDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2002-07-30 | — | — | US | disclosed |
| JP-2002205965-A | NEW BIPHENYL COMPOUND HAVING REACTION-ACTIVE GROUP AND METHOD FOR PRODUCING THE SAME | KANTO DENKA KOGYO CO LTD | 2002-07-23 | — | — | JP | disclosed |
| WO-2001038337-A2 | PROTECTING GROUPS USEFUL IN THE SYNTHESIS OF POLYSACCHARIDES, NATURAL PRODUCTS, AND COMBINATORIAL LIBRARIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2001-05-31 | — | — | WO | disclosed |
| EP-1004621-A1 | GAMMA-RAY STABILIZER AND THERMOPLASTIC POLYMER COMPOSITION CONTAINING THE SAME | TEIJIN LIMITED (JP) | 2000-05-31 | — | — | EP | disclosed |
| US-5700938-A | Intermediates for imidazopyridine derivatives | EISAI CO., LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| US-5618969-A | Intermediates for imidazopyridines | EISAI CO., LTD. (JP) | 1997-04-08 | — | — | US | disclosed |
| US-5608068-A | Process for the preparation of imidazopyridine derivatives and intermediates | EISAI CO., LTD. (JP) | 1997-03-04 | — | — | US | disclosed |
| US-5587504-A | Sulfonyloxy-biphenylcarboxylic ester derivatives which are intermediates | EISAI CO., LTD. (JP) | 1996-12-24 | — | — | US | disclosed |
| US-5583229-A | Process for the preparation of imidazopyridine derivatives | EISAI CO., LTD. (JP) | 1996-12-10 | — | — | US | disclosed |
| US-5559236-A | Intermediates for substituted biphenylmethylmidazopyridine angiotensin II antagonists | EISAI CO., LTD. (JP) | 1996-09-24 | — | — | US | disclosed |
| US-5557002-A | Process for the preparation of biphenyl containing intermediates useful in making angiotensin II receptor antagonists | EISAI CO., LTD. (JP) | 1996-09-17 | — | — | US | disclosed |
| US-5554757-A | Process for the preparation of imidazopyridine derivatives, and intermediates therefore | EISAI CO., LTD. (JP) | 1996-09-10 | — | — | US | disclosed |
| EP-0664316-A1 | Polycarbonate composition having improved resistance to gamma-ray radiation | TEIJIN LIMITED (JP) | 1995-07-26 | — | — | EP | disclosed |
| JP-H0761977-A | BIPHENYLOXAZOLINE DERIVATIVE | EISAI KAGAKU KK | 1995-03-07 | — | — | JP | disclosed |
| JP-H0761952-A | PRODUCTION OF HALOMETHYLBIPHENYLCARBOXYLIC ACID ESTER DERIVATIVE | EISAI KAGAKU KK | 1995-03-07 | — | — | JP | disclosed |
| EP-0627433-A1 | PROCESS FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE AND INTERMEDIATE | Eisai Co., Ltd. (JP) | 1994-12-07 | — | — | EP | disclosed |
| EP-0328643-B1 | (alpha)-HYDROPEROXYISOPROPYLPHENYL COMPOUNDS AND PROCESS FOR THEIR PREPARATION | TERUMO CORP (JP) | 1994-07-06 | — | — | EP | disclosed |
| US-5043142-A | Measuring peroxide-active substances | TERUMO KABUSHIKI KAISHA (JP) | 1991-08-27 | — | — | US | disclosed |
| EP-0328643-A1 | (alpha)-HYDROPEROXYISOPROPYLPHENYL COMPOUNDS AND PROCESS FOR THEIR PREPARATION | TERUMO KABUSHIKI KAISHA (JP) | 1989-08-23 | — | — | EP | disclosed |
| EP-0328643-A1 | (alpha)-HYDROPEROXYISOPROPYLPHENYL COMPOUNDS AND PROCESS FOR THEIR PREPARATION | TERUMO KABUSHIKI KAISHA (JP) | 1989-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (18 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212919-A1 | PROTEIN CROSS-LINKING INHIBITOR | BAZ2B, PRMT1, BRIX1 | IDO1 1046/4885TSHR 2155/4885APP 3361/4885 |
| US-20060074240-A1 | Process for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline | CYP1A1, CYP2F1, CYP1A2 | IDO1 375/4885TSHR 2534/4885APP 3365/4885 |
| US-20040220389-A1 | Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries | FUT5, FUT6, UGCG | IDO1 2393/4885TSHR 2453/4885APP 4709/4885 |
| US-20240383893-A1 | Hydroxamic Acid Compound Having ENPP1 Inhibitory Activity and Use Thereof | ENPP1, ENPP2, ENPP3 | IDO1 1680/4885TSHR 4195/4885APP 1320/4885 |
| US-20070123705-A1 | Process for the Synthesis of Derivatives of 2,3-Dihydro-1,4-Dioxino-[2,3-f] Quinolines | CYP1A1, CYP2F1, CYP4X1 | IDO1 427/4885TSHR 2493/4885APP 3737/4885 |
| US-20100087645-A1 | NOVEL BISBORON COMPOUND | KCNMB4, CA2, NR0B2 | IDO1 4044/4885TSHR 977/4885APP 3735/4885 |
| US-20080220265-A1 | Cross-linkable Iridium Complexes and Organic Light-Emitting Devices Using the Same | MTCL3, LIG4, L1CAM | IDO1 227/4885TSHR 4271/4885APP 3918/4885 |
| US-20030181690-A1 | Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries | FUT5, FUT6, UGCG | IDO1 2393/4885TSHR 2453/4885APP 4709/4885 |
| US-20020187983-A1 | Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline | CYP1A1, CYP2F1, CYP1B1 | IDO1 317/4885TSHR 2569/4885APP 3418/4885 |
| US-20120107989-A1 | CROSS-LINKABLE IRIDIUM COMPLEXES AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME | MTCL3, LIG4, L1CAM | IDO1 227/4885TSHR 4271/4885APP 3918/4885 |
| US-20210230150-A1 | COMPOUNDS FOR USE IN PREVENTING OR TREATING CANCER | UGT1A3, UGT1A1, UGT1A6 | IDO1 2846/4885TSHR 4736/4885APP 3919/4885 |
| US-12006311-B2 | Compounds for use in preventing or treating cancer | UGT1A3, UGT1A1, UGT1A6 | IDO1 2846/4885TSHR 4736/4885APP 3919/4885 |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | IDO1 4313/4885TSHR 1973/4885APP 2681/4885 |
| US-20040186123-A1 | Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline | CYP1A1, CYP2F1, CYP1B1 | IDO1 317/4885TSHR 2569/4885APP 3418/4885 |
| US-20210188871-A1 | NITROGEN CONTAINING HETEROCYCLE SUBSTITUTED BENZOXAZINE OXAZOLIDINONE COMPOUND AND PREPARATION METHOD AND USE THEREOF | XDH, NOX5, TBC1D15 | IDO1 367/4885TSHR 1181/4885APP 1539/4885 |
| US-20180066295-A1 | DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES | ADA, CDA, DCTD | IDO1 1161/4885TSHR 1415/4885APP 3348/4885 |
| US-11332477-B2 | Nitrogen containing heterocycle substituted benzoxazine oxazolidinone compound and preparation method and use thereof | XDH, NOX5, TBC1D15 | IDO1 367/4885TSHR 1181/4885APP 1539/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | IDO1 4313/4885TSHR 1973/4885APP 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.